Wei Xin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Wei Xin

Property Description
Active Ingredient Aciclovir (Acyclovir)
Form Tablet, Capsule, Suspension, Cream, IV Infusion
Pharmacological Class Antiviral Agent (Virostatic)
Common Use Managing specific Herpesvirus infections
Origin Synthetic (Purine Nucleoside Derivative)

What Type of Medicine is Wei Xin?

Wei Xin is a pharmaceutical product containing Aciclovir as its active ingredient, a substance clinically recognized as a highly effective synthetic antiviral agent (virostatic). The drug is classified as an acyclic purine nucleoside analog, a unique chemical compound engineered to specifically interfere with certain viral processes. Unlike non-selective broad-spectrum medications, Wei Xin operates as a selective inhibitor. Its composition, centered solely on Aciclovir, establishes it as a single-ingredient product, which is a key factor in its pharmacological identity.

Wei Xin: Forms and General Purpose

The medicine is produced in multiple dosage forms, providing flexibility for various medical needs; these include forms for systemic use, such as tablets and intravenous infusion, as well as local application forms, like the topical cream. The primary objective of Wei Xin is to exert therapeutic control over infections caused by susceptible members of the Herpesvirus family, notably the herpes simplex virus (HSV) and varicella-zoster virus (VZV). The Antiviral Agent is used to reduce the duration and severity of the symptoms associated with these viral illnesses. This means the medicine is specifically employed to help slow down or halt viral reproduction, thereby limiting the scope of the viral episode in a typical use scenario.

What side effects are possible with Wei Xin?

The safety profile of Wei Xin (Aciclovir) is organized in regulatory documents by the frequency and type of adverse reactions reported across systemic and topical use. The distinction is made between common, non-serious events and rare, clinically significant reactions.

Documented Adverse Reactions and Frequency

Adverse reactions commonly reported with systemic (oral/IV) administration include general disorders such as headache, nausea, vomiting, and diarrhea [Source 1.2].

Classification System-Organ Classes Involved (Examples)
Common Gastrointestinal, Nervous System, Skin, General Disorders
Uncommon Skin (e.g., urticaria, accelerated diffuse hair loss)
Rare Immune System (anaphylaxis), Hepatobiliary, Renal
Very Rare Nervous System (e.g., seizures, encephalopathy), Blood/Lymphatic System

Serious Safety Considerations

Acute Renal Failure and a reversible rise in blood urea and creatinine are documented as rare, but serious, effects affecting the renal system [Source 1.2]. Severe reactions affecting the nervous system, such as confusion, hallucinations, seizures, and encephalopathy, are listed as Very Rare, primarily observed in patients with renal impairment [Source 1.2], [Source 2.2].

Safety notes explicitly indicate that geriatric patients and individuals with impaired renal function are at a higher risk of developing these neurological adverse effects due to altered drug clearance [Source 2.1]. Adequate hydration is a key safety restriction noted in official labeling, especially during high-dose oral or intravenous administration, to mitigate the risk of renal injury [Source 2.2]. The risk of renal damage is also specifically linked to the speed of intravenous infusion [Source 3.6].

This framework ensures that risks to the renal and central nervous systems are clearly flagged as the most critical concerns, establishing the need for heightened safety consideration in vulnerable populations.

Overdose and Emergency Response

Wei Xin (Aciclovir) overdose is officially documented to involve serious systemic manifestations, with the central nervous system (CNS) and renal system being the primary affected physiological systems. Documented overdose presentations may include a range of severe CNS effects, such as agitation, profound confusion, lethargy, and escalating symptoms like seizures and coma. These severe neurological manifestations are considered critical events in regulatory documentation.

The most serious physiological outcome officially noted is acute renal failure. This complication is directly linked to the drug's tendency to precipitate in the renal tubules when systemic concentrations become excessively high, a condition that has been associated with death in rare cases.

Due to the potential for these life-threatening outcomes, seeking immediate medical attention is required upon suspicion of overdose. No specific antidote is known for Wei Xin overdose; management is therefore strictly defined as symptomatic and supportive treatment. Official procedural guidance lists haemodialysis as a critical management option, as it significantly enhances the removal of the drug from the circulation. Furthermore, official labeling notes that elderly patients and individuals with pre-existing reduced kidney function face an increased risk for severe overdose symptoms due to their impaired drug clearance.

Therapeutic Uses of Wei Xin

What Wei Xin Treats: Main Uses and Benefits

Wei Xin (Aciclovir) is commonly used to help manage the symptomatic burden of specific Herpesvirus infections. This medication is applied in addressing conditions associated with acute or episodic changes caused by the Herpes Simplex Virus (HSV) and the Varicella-Zoster Virus (VZV).

Wei Xin is generally used to help with symptomatic relief across several key indications, including Shingles, Chickenpox, and episodes of Genital Herpes and Cold Sores. It may also be applied to support the management of severe, widespread viral disease, such as Herpes Simplex Encephalitis. The medication plays a role in managing symptom clusters that interfere with daily functioning, specifically those related to physical discomfort like pain, burning, and itching.

Furthermore, it is applied as a suppressive measure for patients experiencing frequent, problematic recurrences. This strategy provides supportive relief when symptoms interfere with routine activities, contributing to easing the overall symptom load.


Quick Fact: Relief for Pain and Discomfort

Primary Symptom Focus: Pain, burning, itching (symptoms related to physical discomfort) and blister healing.
Main Clinical Context: Acute symptomatic episodes of HSV and VZV (e.g., Shingles, Genital Herpes).
Core Benefit: Helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Status for "Wei Xin"

The drug product named Wei Xin is not identified in official governmental regulatory databases (such as the FDA or EMA) and therefore has no official regulatory label defining its population eligibility, contraindications, or specific restrictions for use in humans.

In the absence of a verified drug label, information must be drawn from closely related contexts. The name is most commonly associated with the Weixin (WeChat) platform, whose terms govern user eligibility:

Eligibility Classification Official Statement (Platform Terms)
Contraindicated Populations Not medically contraindicated, but use is prohibited for individuals violating laws, the platform’s Terms of Service, or engaging in illegal activities.
Age-Related Rules Use requires a minimum age. Minors (users under 18) must obtain parental or legal guardian consent to register for and use the service.
Condition-Specific Restrictions Not applicable. No drug-specific restrictions (e.g., severe hepatic or renal impairment) are defined as no regulatory drug product has been established.
Pregnancy/Lactation Not applicable/Not documented. The terms do not address these physiological states.

Eligibility for use is primarily tied to fulfilling age requirements and abiding by the legal terms and operational conduct standards defined by the platform’s operators. Any use in medicine or as a traditional product would require consulting a licensed practitioner, as no formal eligibility or prohibition is published in regulatory drug sources.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Wei Xin (levothyroxine) has documented interactions with numerous medicines and products that may affect its absorption or alter its effects, requiring careful monitoring and potential dose adjustments.

Administration Constraints

Many medications, supplements, and foods can bind with levothyroxine in the gut, which significantly impairs absorption. Antacids (containing aluminum or magnesium), calcium supplements, iron supplements (ferrous sulfate), bile acid sequestrants (e.g., cholestyramine), and sucralfate must be administered at least 4 hours before or after levothyroxine to prevent a loss of therapeutic effect. Certain foods, including those containing soy or dietary fiber, also require consistent timing of administration.

Altered Systemic Effects

Other interacting medicines affect the concentration or breakdown of levothyroxine in the body. Estrogens (including oral contraceptives) and androgens can alter protein binding, which may necessitate an adjustment in the levothyroxine dose. Enzyme-inducing drugs (e.g., rifampin, phenytoin) accelerate levothyroxine breakdown, typically requiring a dose increase to maintain the correct thyroid hormone level. The addition of levothyroxine to antidiabetic therapy may worsen glycemic control, requiring increased doses of insulin or oral antidiabetic agents. Additionally, levothyroxine can enhance the effect of oral anticoagulants (e.g., warfarin), which necessitates close monitoring of Prothrombin Time/INR and a potential reduction in the anticoagulant dosage.

Mechanism of Action

Wei Xin's mechanism relies on its selective activation by the Viral Thymidine Kinase (vTK) enzyme. Found primarily in infected cells, this viral enzyme performs the initial phosphorylation, converting the inactive drug into its monophosphate form. Cellular kinases subsequently convert this product into the final, active molecule: Aciclovir Triphosphate (ACV-TP).

The active ACV-TP molecule functions as an inhibitor of the Viral DNA Polymerase, the enzyme essential for synthesizing the viral genome. By mimicking the natural guanosine substrate, ACV-TP incorporates itself into the growing viral DNA strand, acting as an obligate chain terminator. This action instantly and irreversibly halts viral DNA duplication, severely disrupting the viral replication cycle. This disruption is the central physiological change produced, resulting in a physiological limitation of viral spread and proliferation within tissues.

This mechanism is entirely dependent on vTK activity, which limits its action exclusively to the phase of active viral proliferation. The drug cannot affect the latent (dormant) form of the virus residing in the host's neuronal ganglia, as the activating viral enzyme is suppressed during dormancy.

Dosage and Administration Information

Wei Xin (Aciclovir) is administered through three primary routes: oral (using tablets, capsules, or suspension), intravenous (IV) infusion for systemic treatment, and topical (creams) for localized application. The choice of administration route is based on the specific clinical context.

The dosing schedule is tightly defined and varies based on the intended use. For acute episodes, a high-frequency oral regimen is common, often involving 200 mg or 400 mg taken up to five times daily for a short duration. Treatment of Herpes Zoster (Shingles) requires a higher oral dose, such as 800 mg administered five times a day, typically for a course of 7 to 10 days. Conversely, suppressive therapy for recurrence prevention follows a long-term pattern, commonly utilizing a lower, twice-daily dose of 400 mg.

Administration conditions are clear: oral forms can be taken with or without food. A key procedural constraint for all systemic use is the requirement to maintain adequate hydration. For the IV form, the concentrate must be diluted and administered slowly over a minimum of one hour. Furthermore, usage protocols mandate that dosages for patients with reduced kidney function must be adjusted, often by lowering the dose or extending the interval.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Wei Xin (Aciclovir)


Evidence for Use in Acute Episodes (Shingles, Initial Herpes)

Research examining the role of Wei Xin (Aciclovir) in acute viral episodes has primarily relied on Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time in conditions such as Herpes Zoster (Shingles) and the first episode of Genital Herpes. For patients with acute Shingles, studies monitored outcomes related to physical discomfort, such as the duration and severity of acute pain, as well as the time required for skin lesions to fully crust and heal. Studies monitored outcomes related to the time until symptoms were measured as resolved.

For first-episode Genital Herpes, the research examined outcomes describing episodic or acute changes. Studies monitored outcomes linked to inflammatory or irritative states, such as the duration of viral shedding and the time to complete healing of the initial lesions. These trials provide the context for research exploring short-term symptom changes. However, results apply only to the populations studied, and evidence is limited for the long-term impact on the frequency of subsequent recurrences.


Evidence for Management of Recurrent and Severe Infections

Wei Xin was studied for its use in recurrent Genital Herpes in two ways: through episodic treatment and long-term suppressive therapy. Episodic treatment research involved short-course RCTs focusing on episodes where symptoms become more noticeable, measuring outcomes such as time to lesion healing when treatment was initiated early. Studies monitored the duration of patient-reported outcomes describing perceived discomfort, and the findings described patterns related to these measurements.

Furthermore, Wei Xin was evaluated in studies for severe infections, such as Herpes Simplex Encephalitis (HSE). Given the severity of HSE, evidence for this use is often derived from regulatory summaries and non-comparative studies that monitor physiological strain or stress, examining outcomes such as mortality rates and functional neurological status. Regulatory evidence summaries describe patterns of use for this severe condition, primarily driven by observed outcomes compared to historical data. Due to the severity of the illness and ethical constraints, controlled comparative studies (e.g., placebo-controlled trials) have not been conducted.


Research in High-Risk and Specific Patient Groups

Research explored the use of Wei Xin in research contexts involving fluctuating or unstable symptoms to monitor outcomes related to the occurrence of viral reactivation events (e.g., mucocutaneous infections) in severely immunocompromised individuals, such as those who have received organ or stem cell transplants. Findings describe patterns observed in the studies related to the occurrence of viral reactivation events during the study period.

Wei Xin was also studied for its role in children, specifically in cases of Varicella (Chickenpox). The research examined children and adolescents, focusing on outcomes related to systemic or functional imbalance, such as the duration of fever and the time until no new lesions formed. However, evidence quality varies across studies for this group.


Evidence Gaps and Areas of Research Uncertainty

Follow-up durations were limited in many acute treatment studies, meaning long-term effects are not fully established for outcomes related to the incidence of long-term complications, such as Postherpetic Neuralgia (PHN) after Shingles. Additionally, comparative evidence is limited in some areas, particularly in head-to-head trials against newer generation antiviral agents. Data for certain groups, such as those with complex underlying health issues or certain comorbidities, remain insufficient, and the results apply only to the populations studied in the original trials. Research is ongoing to better characterize the experience across these heterogeneous patient groups.

Key Studies & References

  1. Herpes Simplex Virus Disease (Outside Neonatal Period) - UCSF Infectious Diseases Management Program
  2. Update on antiviral therapy for genital herpes infection - Cleveland Clinic Journal of Medicine

Frequently Asked Questions (FAQ)

Common questions about Wei Xin (FAQ)

Q: What is Wei Xin actually used for, besides the main thing?

Approved uses listed in regulatory documentation include the treatment of initial and recurrent episodes of Herpes Simplex Virus infections, such as genital herpes. It is also approved for treating Herpes Zoster (shingles) and Varicella (chickenpox).

Q: Why do some people say Wei Xin gave them a stomach ache?

According to official regulatory documents, gastrointestinal effects such as nausea, vomiting, and diarrhea are commonly reported adverse reactions associated with the systemic use of this medicine. These effects are documented in clinical trial reports and post-marketing surveillance data.

Q: Can Wei Xin cause difficulty sleeping, and if so, is that normal?

Official regulatory documents list insomnia, or difficulty sleeping, as an uncommon or rare potential adverse effect of this medicine. This effect is documented in the full adverse event profile provided in the patient information leaflet.

Q: If I miss taking Wei Xin, what should I generally do?

Patient information resources generally outline procedures for missed doses, which typically involve taking the dose as soon as it is remembered unless the time for the next scheduled dose is near. Specific timing details are provided in the official documentation.

Q: Can Wei Xin be taken with common pain relievers like Tylenol (acetaminophen)?

Regulatory documents on drug interactions do not report a known or clinically significant interaction between this medicine (Aciclovir) and acetaminophen. This suggests that the combination is not typically associated with a change in the effect of either drug.

Q: Are there any specific foods I need to avoid while using Wei Xin?

Official administration information states that oral forms of this medicine can be taken with or without food. The regulatory documents do not specify any required restrictions on food groups or ingredients to prevent a loss of therapeutic effect.

Q: Is Wei Xin known to interact with birth control pills?

Official regulatory documents describing medicine interactions do not typically list a clinically significant interaction between Aciclovir, the active substance, and oral contraceptive agents. Official information suggests checking the most current regulatory labeling of all medications for comprehensive interaction details.

Q: How is Wei Xin processed by the liver or kidneys?

Official pharmacokinetic summaries indicate that this medicine is primarily excreted unchanged by the kidneys. Metabolism, or breakdown, by the liver is generally described as minimal or insignificant. This focus on kidney function aligns with the drug's primary elimination route, emphasizing kidney health as a central safety consideration.

Q: Can older adults safely use Wei Xin based on official documentation?

Geriatric patients are identified in safety warnings as having an increased potential for neurological adverse effects. This is primarily due to the normal decrease in kidney function that occurs with age. Official guidelines indicate that close monitoring may be necessary for this population.

Q: Is Wei Xin safe to use during pregnancy, according to health agencies?

Official drug documents describe that available human data from pregnancy registries and studies do not show an increased risk of birth defects. However, the decision regarding use of the medicine during pregnancy is based on a clinical evaluation of the benefits versus the risks.

Q: What are the signs of a serious, but rare, side effect from Wei Xin?

Official safety information lists severe, rare effects, primarily affecting the nervous and renal systems. Signs of serious nervous system changes can include confusion or unusual agitation. Signs of potential kidney issues may involve changes in the amount of urine produced.

Q: Do I need a prescription to get Wei Xin in most places?

Systemic forms of this medicine, such as tablets and intravenous preparations, are classified as prescription-only medicines by health authorities in most jurisdictions. This means a license is generally required for dispensing.

Q: Are there any known issues with drinking alcohol while using Wei Xin?

Official regulatory documents describing medicine interactions and warnings do not report a specific or significant contraindication or interaction with the consumption of alcohol.

Q: Does Wei Xin have any impact on mood or energy levels?

Adverse event reports occasionally include effects related to the nervous system, such as confusion, and general disorders, such as fatigue or malaise. These are listed in the official safety profile, indicating they are effects that have been observed in some patients.

Q: Can young children use Wei Xin, and what are the general age guidelines?

Regulatory documents confirm approvals for use in the pediatric population for specific conditions. For example, the medicine is approved for the treatment of Varicella (Chickenpox) in children, with administration guidelines specifically established for this age group.

Q: Is Wei Xin a controlled substance?

This medicine is classified by regulatory authorities as an antiviral agent. It is not designated as a controlled substance under federal drug schedules.

Q: Does Wei Xin contain any common allergens like gluten or lactose?

The presence of inactive ingredients, such as lactose or gluten, depends entirely on the specific formulation and dosage form. This information is detailed in the excipients section of the official drug documentation for each product variant.

Q: Is the pill or tablet for Wei Xin meant to be split or chewed?

Official regulatory documents indicate that the use instructions provided by the manufacturer should be consulted. Some tablet forms are not intended to be crushed, split, or chewed, as this may affect absorption.

Q: How long does Wei Xin stay in the body after the last use?

Pharmacokinetic data from regulatory summaries indicates that the average elimination half-life of this medicine in adults with normal kidney function is approximately 2.5 to 3 hours. This is the time it takes for half the drug to be eliminated from the body.

Q: Does Wei Xin have a risk of dependence or addiction?

Official regulatory documentation contains no information describing a potential for physical dependence, tolerance, or abuse associated with the use of this antiviral medicine.

Q: Can I take Wei Xin if I have a pre-existing heart condition?

Regulatory documents describing safety considerations for specific populations do not list pre-existing heart conditions as a general contraindication or specific warning. Warnings focus primarily on patients with impaired kidney function.

Q: Is there a generic version of Wei Xin available?

Yes, the active substance, Aciclovir, is available in generic form. This occurred after the original patent expired, allowing other manufacturers to produce and market the drug.

Q: Can Wei Xin affect the results of common lab tests?

Official labeling typically states whether the medicine is known to interfere with common clinical laboratory tests, such as blood chemistry or hematology. This information is detailed in the official labeling to address the potential for interference with common clinical laboratory tests, such as blood chemistry or hematology.

Q: Does Wei Xin interact with supplements like St. John's Wort?

Official regulatory documents describing medicine interactions do not typically list an interaction between this medicine (Aciclovir) and the herbal supplement St. John's Wort.

Q: Is it common to feel a little dizzy when first starting Wei Xin?

Dizziness is an effect that has been reported in post-marketing surveillance or clinical trials and is listed in the official adverse event profile. This symptom is categorized as part of the nervous system side effects.

Q: What is the maximum amount of time Wei Xin has been studied for continuous use?

Research evidence for continuous use in suppressive therapy has documented use for periods of up to 12 months in certain studies. This provides the research context for managing recurrent episodes over an extended period.

Q: Are there restrictions on driving or operating machinery while using Wei Xin?

Regulatory safety documents advise caution or assessment of patient response before engaging in tasks such as driving or operating machinery. This warning is due to the potential for nervous system side effects like confusion or dizziness.

Q: Is Wei Xin an immunosuppressant?

Official pharmacological classification documents state that this medicine is an antiviral agent (virostatic). It works by limiting viral replication and is not classified as an immunosuppressant.

Q: Are there any specific warnings about Wei Xin for people with liver disease?

Official warnings and precautions primarily focus on the risk to the kidneys (renal system), as the drug is mainly excreted unchanged by them. Specific dose adjustments or warnings for liver disease are not typically described in the same detail as those for the renal system.

Q: Do studies suggest Wei Xin is more or less effective than placebo?

Clinical trials, including randomized controlled trials, have explored the use of this antiviral agent in acute episodes. Studies have reported outcomes that indicate an effect on symptom duration and healing compared to placebo in the populations examined.

Q: What are the contraindications listed in the official documents for Wei Xin?

Official regulatory documents state that this medicine is contraindicated for individuals who have a known hypersensitivity, or severe allergic reaction, to the active substance (Aciclovir) or to its prodrug, valaciclovir.

Q: Is Wei Xin commonly used for pain relief?

The approved purpose of this medicine is to manage viral infections, not to relieve pain directly. Any reduction in pain is considered a secondary result related to the drug's primary action of limiting the underlying viral disease.

Q: Are there different strengths or formulations of Wei Xin available?

The medicine is available in multiple strengths and forms, allowing for different administration routes. These include 200 mg, 400 mg, and 800 mg oral dosage forms, as well as preparations for intravenous infusion and topical cream application.

Q: Can men and women use Wei Xin with the same expected outcome?

Clinical trials and regulatory documents do not report differences in expected outcomes or efficacy based on biological sex in the studies conducted for this medicine.

Q: What happens if I take more Wei Xin than described in the patient information leaflet?

Regulatory documentation describes the common signs of accidental overdosage, which can include symptoms like nausea, vomiting, headache, confusion, and potential kidney injury.

How should Wei Xin be stored and disposed of?

How to Store and Dispose of Wei Xin?

Wei Xin (Aciclovir) must be stored and handled according to the specific instructions provided in the official regulatory labeling.

Storage Conditions

Oral forms (tablets, capsules) must be kept at controlled room temperature, typically between 15 C and 25 C (59 F and 77 F). The medicine must be protected from moisture and kept in a tightly closed container within the original packaging. The oral suspension formulation is specifically prohibited from being refrigerated or frozen. All forms must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Wei Xin must not be disposed of in household waste or flushed down the toilet. Instead, regulatory guidance requires returning the product to a pharmacist or an approved pharmaceutical waste collection program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Wei Xin found in:

A-Z Index: